Delivering genetic medicines from promise to performance

Mirai is the development partner of choice for any biotech seeking to optimize performance and accelerate translation of any genetic medicine from concept to the clinic.

Design

Generatively design optimized cargo for highly potent and targeted genetic medicines
Delivery

Unlock delivery of genetic medicines to any tissue and any cell type
Manufacturing

Enable seamless translation of drug development from research through commercialization

The biotech industry’s first open end-to-end platform for genetic medicines

See How We Do It

Join the partners already accelerating their programs with Mirai.

We’re enabling the leading innovators in genome engineering, tRNA, mRNA, DNA, and more.

Partner with Mirai

Our innovation will unlock delivery of any cargo to any tissue.

Currently, genetic medicine delivery is limited to a small number of cell types with a narrow therapeutic window. Mirai’s platform is designed to understand the rules of delivery, enabling access to any tissue and any cell type. It has already unlocked previously inaccessible cell types with ML-derived lipids that outperform today’s commercial lipids.

Delivery innovation:

Liver

CNS

Lung

Immune Cells

Pancreas

Muscle

Fat Cell

HSCs

Kidney

Vaccines

We co-create genetic medicines with our partners to transform concepts to medicines faster.

Mirai’s platform provides access to end-to-end development capabilities with innovation at every step.

Our approach

1

Generative design of cargo and delivery vehicles

Our machine-learning models enable rapid iterative learning to design functional medicines optimized to effectively deliver therapeutic cargo precisely where needed.
2

High throughput in vivo multiplexing

Our unique barcoding approach generates robust, high quality in vivo data, testing thousands of chemistry, formulation, and cargo compositions simultaneously to develop highly potent and targeted genetic medicines.
3

Co-optimization of design, delivery, and manufacturing

Our platform employs extensive data optimization loops, learning from each tested composition to ensure the best possible formulation and manufacturing strategy for each medicine.